Renal Drugs

64
UCL SCHOOL OF PHARMACY BRUNSWICK SQUARE Structure/activity of key renal drugs: furosemide/ bendroflumethiazide Dr Stephen Hilton

description

Drugs for renal impairment.

Transcript of Renal Drugs

Page 1: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Structure/activity of key renal

drugs:

furosemide/ bendroflumethiazide

Dr Stephen Hilton

Page 2: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Focus of the Lecture

Page 3: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

• Urinary system:

– Two kidneys

– Two ureters

– One bladder

– One urethra

– Each kidney has approximately one million

nephrons, which filter water and other

substances out of the blood to produce urine.

Renal Regulation

Page 4: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE The Nephron

Page 5: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE The Nephron

Page 6: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Mechanism of Action of Diuretics

Page 7: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

• Synthesized accidentally in an attempt to create more potent carbonic anhydrase inhibitors.

• They act by inhibiting sodium reabsorption at the cortex level, distal to the loop of Henle.

• They exert their effect from the luminal side of the nephron membrane thus, must be filtered to reach the site of action.

Thiazide and thiazide-like diuretics

Page 8: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

1. Mechanism

• Thiazide diuretics are absorbed from the

gastrointestinal (GI) tract and produce diuresis within

1—2 hours.

• They are secreted into the lumen of the proximal

tubule via an organic acid carrier.

• They exert effects only after reaching the lumen.

Thiazide diuretics

Page 9: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Thiazides inhibit active reabsorption of sodium chloride (NaCl) in

the distal convoluted tubule by interfering with NCC (Na+—Cl-

cotransporter) a specific Na+/Cl- transport protein, resulting in the

net excretion of Na+ and an accompanying volume of water.

• These agents increase excretion of

» Cl-

» Na+

» K+

» at high doses, HCO3-

• They reduce excretion of calcium - Ca 2+.

Thiazide diuretics

Page 10: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Thiazide diuretics can be derivatives of sulfonamides

(sulfonamide diuretics).

– Many also inhibit carbonic anhydrase, resulting in

diminished bicarbonate (HCO3-) reabsorption by the

proximal tubule.

Thiazide diuretics

Page 11: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Therapeutic uses:

a) Thiazide diuretics are the preferred class of diuretic for

treatment of hypertension when renal function is

normal; they are often used in combination with other

antihypertensive agents to enhance their blood

pressure-lowering effects.

a) These agents reduce the formation of new calcium

stones in idiopathic hypercalciuria.

Thiazide diuretics

Page 12: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

c) Thiazide diuretics may be useful in patients with diabetes insipidus that is not responsive to antidiuretic hormone (ADH).

d) These agents are often used in combination with a potassium-sparing diuretic to manage:

– mild cardiac edema

– cirrhotic or nephrotic edema

– edema produced by hormone imbalances

– Ménière's disease (a disorder of the inner ear that can affect hearing and balance.)

Thiazide diuretics

Page 13: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Thiazide diuretics

• Largest, most commonly prescribed class of diuretics

• Mechanism of action: to block Na+ reabsorption and

increase potassium and water excretion

• Primary use: to treat mild to moderate hypertension

– Also indicated to reduce edema associated with

heart, hepatic, and renal failure

Page 14: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Thiazide development

Page 15: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Chloramphenamide became a key intermediate in the

development of diuretics that lack the undesirable properties

of CA inhibitors

When chloramphenamide was treated with acylating agents,

cyclization resulted in the formation of thiazides. The use of

aldehydes or ketones in place of the acylating reagents

yielded the corresponding dihydro derivatives. The products

of these reactions became known as thiazides and

hydrothiazides, respectively.

The thiazides were the first orally effective saluretic agents

where diuretic activity was not influenced by the patient’s

acid-base status.

Thiazide and thiazide-like diuretics

Page 16: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

They are generally medium potency diuretics.

The first thiazide in the market is chlorthiazide suffered poor GI absorption and low bioavailability.

Hydrochlorthiazide is the second member introduced to the market with higher bioavailability.

The main side effects are the possibility of inducing slight hyperglycemia and hyperlipidemia.

Thiazide and thiazide-like diuretics

Page 17: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

• Thiazide like drugs don’t have true thiazide ring but share the same mechanism of action and chemically related.

• All members are available in oral forms except chlorthiazide ( oral and parentral): no clinical significance for their parentral forms.

Thiazide and thiazide-like diuretics

Page 18: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Thiazide and thiazide-like diuretics

Page 19: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Thiazides – structure activity

1) The 2-position can tolerate small alkyl groups such as CH3. 2) Substituents in the 3-position determine the potency and duration of action of the thiazides. 3) Saturation of C-N bond between the 3 and 4 positions of the benzothiadiazine-1,1-dioxide nucleus increases the potency of this class of diuretics approximately 3-10 fold. 4) Direct substitution of the 4-, 5-, or 8-position with an alkyl group usually results in diminished diuretic activity, 5) Substitution of the 6-position with an activating group is essential for diuretic activity. The best substituent include Cl-, Br-, CF3-, and NO2- groups. 6) The sulfamoyl group in the 7-position is essential for diuretic activity.

Page 20: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Physicochemical properties and SAR

N2 proton is acidic due to electron withdrawing effect

of sulphone group (pKa = 8.5). Sodium salt is water

soluble for i.v. administration.

Need electron withdrawing group at C6 (e.g. CF3) for

diuretic activity. CF3 substituent gives greater lipid

solubility and longer duration of action than Cl.

Loss of sulphonamide at C7 greatly reduced diuretic

activity. 3,4-dihydro derivatives 10x better diuretics

than unsaturated. Lipophilic group at C3 gives

increased potency.

Bendroflumethiazide

Page 21: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

ADME

Rapidly absorbed orally. Excreted primarily

unchanged into the urine

ADRs

Long-term use can cause hypokalaemia and

hypomagnesaemia.

Bendroflumethiazide

Page 22: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Interactions

Increased risk of hyponatraemia with

carbamazepine. Enhances hypotensive effect of

other anti-hypertensives. Hypokalaemia may

increase toxicity of some anti-arrhythmics, risk of

arrhythmias with some anti-psychotics and beta-

blockers, and toxicity of cardiac glycosides.

Dosage form

2.5 mg o.m. Only tablet dosage form available.

Bendroflumethiazide

Page 23: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide

Page 24: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide retrosynthesis

Page 25: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 26: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 27: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 28: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 29: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 30: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 31: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 32: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 33: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 34: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Bendroflumethiazide synthesis

Page 35: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

active in “loop” of Henle

Furosemide

Bumetanide

Torasemide

Ethacrynic acid

Loop diuretics - Furosemide

Page 36: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

edema: cardiac, pulmonary or renal

chronic renal failure or nephrosis

hypertension

hypercalcemia

acute and chronic hyperkalemia

Loop diuretics – Clinical use

Page 37: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Mechanism:

• absorbed by the GI tract • eliminated by:

1. filtration 2. tubular secretion;

• some elimination occurs via the hepatic—biliary route.

• They are administered either orally or parenterally.

• Diuresis occurs within: – 5 minutes of intravenous (IV) administration – 30 minutes of oral administration.

Loop diuretics - Furosemide

Page 38: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

orally administered, rapid absorption

rapid onset of action

bound to plasma proteins: displaced by warfarin,

increase toxicity of cephalosporin antibiotics and lithium

additive toxicity with other ototoxic drugs

inhibitors of organic acid ion transport decrease potency (i.e.

probenecid, NSAID’s)

Loop diuretics - Pharmacokinetics

Page 39: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Loop diuretics inhibit active NaCl reabsorption in the

thick ascending limb of the loop of Henle by inhibiting

NKCC2, a specific Na+/K+/2 Cl- cotransporter.

Because of the high capacity for NaCl reabsorption in

this segment, agents active at this site markedly

increase water and electrolyte excretion and are

referred to as high-ceiling diuretics.

These agents:

reduce reabsorption of Cl- and Na+ and increase K+, magnesium (Mg2+), and Ca2+ excretion.

Loop diuretics - Furosemide

Page 40: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Furosemide is an acidic drug. It

contains a carboxylic acid

functional group that has a pKa

of 3.9.

Furosemide

The sulfonamide nitrogen is not basic as it does not have a lone pair of

electrons available to accept a proton

(sulfonamides are often weak acids).

The secondary amine is a very weak base

(lone pair is delocalised over the aromatic ring),

Does not behave as a base under physiological pH conditions

Page 41: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Furosemide is an acidic drug. It

contains a carboxylic acid

functional group that has a pKa

of 3.9.

Furosemide

For an acidic drug, the higher the pH, (i.e. more basic)

the greater the proportion that will be deprotonated and

therefore negatively charged.

Acidic drugs are more soluble at high pHs, as a greater

proportion will be in the charged and highly polar form.

In dextrose saline at pH 4, approximately 50% of a dose

of furosemide will be protonated (-COOH) and 50%

deprotonated (-COO–).

Page 42: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Retrosynthesis

Page 43: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Retrosynthesis

Page 44: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Retrosynthesis

Page 45: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Retrosynthesis

Page 46: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Retrosynthesis

Page 47: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Retrosynthesis

Page 48: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 49: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 50: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 51: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 52: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 53: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 54: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 55: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 56: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 57: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 58: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 59: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 60: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 61: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE Furosemide Synthesis

Page 62: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Page 63: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE

Page 64: Renal Drugs

UCL SCHOOL OF PHARMACY

BRUNSWICK SQUARE